NCT07147335View on ClinicalTrials.gov

The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients

RecruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

May 16, 2025

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2028

Conditions
CirrhosisHepotacellular Carcinoma
Interventions
DIAGNOSTIC_TEST

serum AKR1B10 levels

Investigators collected blood from the patients every three months to test their serum AKR1B10 levels.

Trial Locations (1)

421001

RECRUITING

University of South China, Hengyang

All Listed Sponsors
lead

The First Affiliated Hospital of University of South China

OTHER